BrainStorm Cell Therapeutics
BCLI
#10400
Rank
$6.62 M
Marketcap
$0.60
Share price
0.00%
Change (1 day)
-62.03%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : $8.62 Million USD

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are $8.62 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$9.59 M5.85%
2023-12-31$9.06 M-20.93%
2022-12-31$11.46 M15.41%
2021-12-31$9.93 M-37.1%
2020-12-31$15.79 M-15.79%
2019-12-31$18.75 M201.95%
2018-12-31$6.21 M12.07%
2017-12-31$5.54 M541.55%
2016-12-31$0.86 M-70.73%
2015-12-31$2.95 M-8.78%
2014-12-31$3.23 M62.86%
2013-12-31$1.98 M71.89%
2012-12-31$1.15 M-7.96%
2011-12-31$1.25 M-18.86%
2010-12-31$1.54 M-38.08%
2009-12-31$2.5 M-15.28%
2008-12-31$2.95 M-15.95%
2007-12-31$3.51 M38.28%
2006-12-31$2.53 M
2006-03-31$8.77 M4913.06%
2005-03-31$0.17 M267.03%
2004-03-31$0.04 M89.7%
2003-03-31$0.02 M118.69%
2002-03-31$0.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
$37.07 B 429,877.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
$1.95 B 22,603.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
$1.08 B 12,469.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$11.00 B 127,465.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$0.51 B 5,869.60%๐Ÿ‡บ๐Ÿ‡ธ USA